In conclusion, our study marks a significant milestone as the first investigation in Bosnia and Herzegovina to examine the predictive role of HLA-DRB1*01 in developing therapeutic resistance in JIA. This evidence concerns the gene HLA-DRB1 and juvenile idiopathic arthritis.